Your browser doesn't support javascript.
loading
Encephalitis with Autoantibodies against the Glutamate Kainate Receptors GluK2.
Landa, Jon; Guasp, Mar; Míguez-Cabello, Federico; Guimarães, Joana; Mishima, Takayasu; Oda, Fumiko; Zipp, Frauke; Krajinovic, Vladimir; Fuhr, Peter; Honnorat, Jerome; Titulaer, Maarten; Simabukuro, Mateus; Planagumà, Jesus; Martínez-Hernández, Eugenia; Armangué, Thais; Saiz, Albert; Gasull, Xavier; Soto, David; Graus, Francesc; Sabater, Lidia; Dalmau, Josep.
Afiliação
  • Landa J; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
  • Guasp M; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
  • Míguez-Cabello F; Service of Neurology, Hospital Clinic, Barcelona, Spain.
  • Guimarães J; Neurophysiology Laboratory, Department of Biomedicine, School of Medicine, Neuroscience Institute, University of Barcelona, Barcelona, Spain.
  • Mishima T; Neurology Department, Centro Hospitalar Universitário São João, Clinical Neurosciences and Mental Health Department, Faculty of Medicine, Porto, Portugal.
  • Oda F; Department of Neurology, Fukuoka University, Fukuoka, Japan.
  • Zipp F; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Krajinovic V; Neurology Department, Focus Program Translational Neurosciences (FTN) and Immunotherapy (FZI), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Fuhr P; University Hospital for Infectious Diseases "Dr. Fran Mihaljevic", Zagreb, Croatia.
  • Honnorat J; Department of Neurology, University Hospital Basel, Basel, Switzerland.
  • Titulaer M; French Reference Center for Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Synatac Team, NeuroMyoGene Institute, INSERM U1217/CNRS UMR5310, University Claude Bernard, Villeurbanne, France.
  • Simabukuro M; Department of Neurology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Planagumà J; Department of Neurology, University of São Paulo Medical School, São Paulo, Brazil.
  • Martínez-Hernández E; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
  • Armangué T; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
  • Saiz A; Service of Neurology, Hospital Clinic, Barcelona, Spain.
  • Gasull X; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
  • Soto D; Neuroimmunology Unit, Neurology Service, Sant Joan de Déu Children's Hospital, University of Barcelona, Barcelona, Spain.
  • Graus F; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
  • Sabater L; Service of Neurology, Hospital Clinic, Barcelona, Spain.
  • Dalmau J; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
Ann Neurol ; 90(1): 101-117, 2021 07.
Article em En | MEDLINE | ID: mdl-33949707
ABSTRACT

OBJECTIVE:

The objective of this study was to report the identification of antibodies against the glutamate kainate receptor subunit 2 (GluK2-abs) in patients with autoimmune encephalitis, and describe the clinical-immunological features and antibody effects.

METHODS:

Two sera from 8 patients with similar rat brain immunostaining were used to precipitate the antigen from neuronal cultures. A cell-based assay (CBA) with GluK2-expressing HEK293 cells was used to assess 596 patients with different neurological disorders, and 23 healthy controls. GluK2-ab effects were determined by confocal microscopy in cultured neurons and electrophysiology in GluK2-expressing HEK293 cells.

RESULTS:

Patients' antibodies precipitated GluK2. GluK2 antibody-specificity was confirmed by CBA, immunoprecipitation, GluK2-immunoabsorption, and GluK2 knockout brain immunohistochemistry. In 2 of 8 samples, antibodies reacted with additional GluK2 epitopes present in GluK1 or GluK3; in both, the reactivity was abrogated after GluK2 immuno-absorption. Six of 8 patients developed acute encephalitis and clinical or magnetic resonance imaging (MRI) features of predominant cerebellar involvement (4 presenting as cerebellitis, which in 2 patients caused obstructive hydrocephalus), and 2 patients had other syndromes (1 with cerebellar symptoms). One of the samples showed mild reactivity with non-kainate receptors (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors [AMPAR] and N-methyl-D-aspartate receptors [NMDAR]) leading to identify 6 additional cases with GluK2-abs among patients with anti-AMPAR (5/71) or anti-NMDAR encephalitis (1/73). GluK2-abs internalized GluK2 in HEK293 cells and neurons; these antibody-effects were reversible in neurons. A significant reduction of GluK2-mediated currents was observed in cells treated with patients' GluK2 serum following the time frame of antibody-mediated GluK2 internalization.

INTERPRETATION:

GluK2-abs associate with an encephalitis with prominent clinicoradiological cerebellar involvement. The antibody effects are predominantly mediated by internalization of GluK2. ANN NEUROL 2021;90107-123.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoanticorpos / Receptores de Ácido Caínico / Encefalite Limite: Animals / Humans Idioma: En Revista: Ann Neurol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoanticorpos / Receptores de Ácido Caínico / Encefalite Limite: Animals / Humans Idioma: En Revista: Ann Neurol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha